Teva Pharmaceutical Industries Ltd

WOLVERINE ASSET MANAGEMENT LLC TEVA

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/8/2023

Shares

4,914

Value ($000)

43

Weight

0.0%

2013 Q4 - 2023 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/8/2023	43	0.0%	4,914	3/31/2023
2022 Q4	2/1/2023	48	0.0%	5,314	12/31/2022
2022 Q3	11/10/2022	42	0.0%	5,314	9/30/2022
2022 Q2	8/3/2022	713	0.0%	94,846	6/30/2022
2022 Q1	5/4/2022	890	0.0%	94,846	3/31/2022
2021 Q4	2/9/2022	1,000	0.0%	124,846	12/31/2021
2021 Q3	11/12/2021	1,216	0.0%	124,846	9/30/2021
2021 Q2	8/13/2021	1,038	0.0%	104,946	6/30/2021
2021 Q1	5/13/2021	1,211	0.0%	104,946	3/31/2021
2020 Q4	2/12/2021	1,591	0.0%	164,946	12/31/2020
2020 Q3	11/13/2020	1,207	0.0%	134,046	9/30/2020
2020 Q2	8/13/2020	802	0.0%	65,046	6/30/2020
2020 Q1	5/13/2020	848	0.0%	94,446	3/31/2020
2019 Q4	2/14/2020	491	0.0%	50,146	12/31/2019
2014 Q1	5/14/2014	132	0.0%	2,500	3/31/2014
2013 Q4	2/14/2014	1,074	0.0%	26,800	12/31/2013